Consolidated Statements of Cash Flows (Unaudited) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating Activities
Net income	$ 403	$ 386
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	695	666
Nuclear fuel amortization	33	25
Allowance for equity funds used during construction	(16)	(10)
Deferred income taxes	199	104
Asset (gains) losses and reserves, net	0	(3)
Changes in assets and liabilities:
Accounts receivable, net	36	(40)
Inventories	(38)	53
Accounts payable	7	15
Accrued pension liability — affiliates	(122)	(229)
Accrued postretirement liability — affiliates	(42)	(148)
Regulatory assets and liabilities	(163)	302
Other assets	(74)	(42)
Other liabilities	(39)	(15)
Net cash from operating activities	879	1,064
Investing Activities
Plant and equipment expenditures	(1,143)	(946)
Restricted cash for debt redemption, principally Securitization	60	58
Notes receivable from affiliate	164	(4)
Proceeds from sale of nuclear decommissioning trust fund assets	652	477
Investment in nuclear decommissioning trust funds	(665)	(489)
Other	(16)	(21)
Net cash used for investing activities	(948)	(925)
Financing Activities
Issuance of long-term debt, net of issuance costs	942	768
Redemption of long-term debt	(837)	(491)
Short-term borrowings - other	254	(119)
Short-term borrowings - Affiliate	(2)	(25)
Dividends on common stock	(277)	(257)
Other	(10)	(2)
Net cash from (used for) financing activities	70	(126)
Net Increase (Decrease) in Cash and Cash Equivalents	1	13
Cash and Cash Equivalents at Beginning of Period	27	30
Cash and Cash Equivalents at End of Period	28	43
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Plant and equipment expenditures in accounts payable	$ 139	$ 155